Minodronic acid is an FPP synthase inhibitor with an IC50 of 3 nM, and also an antagonist of P2X2/3 receptors with an IC50 of 62.7 µM. Minodronic acid induces tumor cell apoptosis and inhibits cell growth. Minodronic acid also suppresses bone resorption. Minodronic acid can be used in research related to osteoporosis and cancer[2].
Molecular Weight:
322.15
Purity:
99.67
CAS Number:
[180064-38-4]
Formula:
C9H12N2O7P2
Target:
Apoptosis,Farnesyl Transferase,P2X Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted